Non-alcoholic fatty liver disease and lipotoxicity

被引:31
作者
Wasilewska, Natalia [1 ]
Lebensztejn, Dariusz Marek [1 ]
机构
[1] Med Univ Bialystok, Dept Pediat Gastroenterol Hepatol Nutr & Allergol, 17 Waszyngtona St, PL-15274 Bialystok, Poland
关键词
non-alcoholic fatty liver disease; lipotoxicity; non-alcoholic steatohepatitis; CIRCULATING OXIDIZED-LDL; METABOLIC SYNDROME; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; HEPATIC STEATOSIS; OXIDATIVE STRESS; VISCERAL FAT; CHILDREN; PATHOGENESIS; OBESITY;
D O I
10.5114/ceh.2021.104441
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Non-alcoholic fatty liver disease (NAFLD) has become the most common liver pathology worldwide due to the rising prevalence of obesity. This term includes changes from simple steatosis to steatohepatitis and fibrosis. It was previously thought to be a hepatic manifestation of metabolic syndrome, but recent literature describes this relation as much more complex and bi-directional. Development of NAFLD is associated with other metabolic syndrome components but it can also exacerbate insulin resistance and increase cardiovascular risk. Recently a lot of attention is brought to the role of lipids and lipotoxicity in pathogenesis and progression of non-alcoholic fatty disease. It seems that some lipid classes can be protective against liver injury while others are harmful in excessive amounts. This study presents an overview of the main lipids involved in the pathogenesis of non-alcoholic fatty liver disease and summarizes their association with lipotoxicity, insulin resistance, oxidative stress and other processes responsible for its progression.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 75 条
[61]   An Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases the Risk for Obesity [J].
Simopoulos, Artemis P. .
NUTRIENTS, 2016, 8 (03)
[62]   Oxidative Stress as a Critical Factor in Nonalcoholic Fatty Liver Disease Pathogenesis [J].
Spahis, Schohraya ;
Delvin, Edgard ;
Borys, Jean-Michel ;
Levy, Emile .
ANTIOXIDANTS & REDOX SIGNALING, 2017, 26 (10) :519-+
[63]   Fatty Liver is Associated With Dyslipidemia and Dysglycemia Independent of Visceral Fat: The Framingham Heart Study [J].
Speliotes, Elizabeth K. ;
Massaro, Joseph M. ;
Hoffmann, Udo ;
Vasan, Ramachandran S. ;
Meigs, James B. ;
Sahani, Dushyant V. ;
Hirschhorn, Joel N. ;
O'Donnell, Christopher J. ;
Fox, Caroline S. .
HEPATOLOGY, 2010, 51 (06) :1979-1987
[64]   Omega-3 fatty acids and nonalcoholic fatty liver disease in adults and children: where do we stand? [J].
Spooner, Melinda H. ;
Jump, Donald B. .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2019, 22 (02) :103-110
[65]   Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies [J].
Tomic, Dunya ;
Kemp, William W. ;
Roberts, Stuart K. .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (10) :1103-1115
[66]   Obesity-Induced CerS6-Dependent C16:0 Ceramide Production Promotes Weight Gain and Glucose Intolerance [J].
Turpin, Sarah M. ;
Nicholls, Hayley T. ;
Willmes, Diana M. ;
Mourier, Arnaud ;
Brodesser, Susanne ;
Wunderlich, Claudia M. ;
Mauer, Jan ;
Xu, Elaine ;
Hammerschmidt, Philipp ;
Broenneke, Hella S. ;
Trifunovic, Aleksandra ;
LoSasso, Giuseppe ;
Wunderlich, F. Thomas ;
Kornfeld, Jan-Wilhelm ;
Blueher, Matthias ;
Kroenke, Martin ;
Bruening, Jens C. .
CELL METABOLISM, 2014, 20 (04) :678-686
[67]   Diagnosis of Nonalcoholic Fatty Liver Disease in Children and Adolescents: Position Paper of the ESPGHAN Hepatology Committee [J].
Vajro, Pietro ;
Lenta, Selvaggia ;
Socha, Piotr ;
Dhawan, Anil ;
McKiernan, Patrick ;
Baumann, Ulrich ;
Durmaz, Ozlem ;
Lacaille, Florence ;
McLin, Valerie ;
Nobili, Valerio .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2012, 54 (05) :700-713
[68]  
Vos MB, 2013, J PEDIAT, V162, P1
[69]   Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease [J].
Wasilewska, Natalia ;
Bobrus-Chociej, Anna ;
Harasim-Symbor, Ewa ;
Tarasow, Eugeniusz ;
Wojtkowska, Malgorzata ;
Chabowski, Adrian ;
Lebensztejn, Dariusz M. .
LIPIDS IN HEALTH AND DISEASE, 2018, 17
[70]   Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis [J].
Yamaguchi, Kanji ;
Yang, Liu ;
McCall, Shannon ;
Huang, Jiawen ;
Yu, Xing Xian ;
Pandey, Sanjay K. ;
Bhanot, Sanjay ;
Monia, Brett P. ;
Li, Yin-Xiong ;
Diehl, Anna Mae .
HEPATOLOGY, 2007, 45 (06) :1366-1374